Syngene reports strong third quarter results

Syngene and the Research and Innovation Circle of Hyderabad (RICH) launch scholarship program for women studying STEM subjects

Syngene reports second quarter results Revenue from operations up 26% to Rs. 768 crores, PAT increased 11% to Rs.102 crores

Syngene reports revenue from operations up 8% in the first quarter

Syngene signs 10-year biologics manufacturing agreement with leading animal health company, Zoetis

Syngene reports full year revenue from operations up 19% to Rs. 2604 Cr

Syngene International takes top honors at CMO Leadership Awards 2022 for contract manufacturing

Syngene releases its first ESG report for FY2020-21 in accordance with the Global Reporting Initiative (GRI)

Syngene reports 10% growth in revenue from operations to Rs.6,414 Mn and raises full-year guidance

Syngene International Announces Extension of Collaboration with Amgen

Syngene through Biocon Foundation partners with NIMHANS for BHUMI

Syngene reports second quarter results Revenue from operations up 17% to Rs. 6,102 Mn, PAT increased 9% to Rs. 920 Mn

Syngene expands biopharma-manufacturing capacity. Sets up a state-of-the-art microbial facility; expands mammalian facility

Syngene announces senior-level appointments Strengthens leadership in USA

Syngene reports first quarter results Revenue from operations up 41% to Rs. 5,945 Mn, PAT increased 33% to Rs. 773 Mn

Syngene reports revenue from operations growth of 13% in the fourth quarter; 12% for the full year

Syngene International extends long term research collaboration with Bristol Myers Squibb until 2030

Inauguration of COVID-19 Vaccination Centre at Syngene International Limited, Biocon Group of Companies

Syngene announces Q3 FY21 results

Syngene and PharmAust collaborate to manufacture GMP-grade Monepantel for Human Clinical Trials